HLA-DR Alpha 2 Mediates Negative Signalling via Binding to Tirc7 Leading to Anti-Inflammatory and Apoptotic Effects in Lymphocytes In Vitro and In Vivo | PLOS ONE
Expression of cellular activation/exhaustion markers on HLA-DR+ and... | Download Scientific Diagram
Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink
A) representative flow cytometry plots of CD38 and HLA-DR expression on... | Download Scientific Diagram
Determination of HLA-DR level in cytotoxic T lymphocytes: a new validated tool to predict breast cancer response to treatment | bioRxiv
Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers | PLOS ONE
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART | Journal of Translational Medicine | Full Text
T cell activation | T cell differentiation | Miltenyi | USA
Cortisol Patterns Are Associated with T Cell Activation in HIV | PLOS ONE
What does HLA-DR expression on CD4 T cells indicate? | Immunopaedia
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia | Nature Communications
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
A Guide to T Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
T-Cell Activation | Sartorius
Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro | Journal of Experimental & Clinical Cancer Research | Full Text
JCI - Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response
Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy
Flow cytometry gating strategy for measuring HLA-DR and CD38 expression... | Download Scientific Diagram
IJMS | Free Full-Text | Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation
A Guide to Regulatory T Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation | ACS Nano
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
Immunophenotyping | CD4+ CD8+ T cell activation | Great Britain
Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients | Annals of the Rheumatic Diseases
